Håvard J. Haugen
University of Oslo, Norway
Håvard received a Master in Chemical Engineering at the Imperial College of Science, Technology and Medicine in London, UK in 2001 and a doctoral engineering in biomaterials from the Technische Universität München in 2004. His PhD thesis was “Development of an implant to heal gastro-oesphageal reflux diseases”. Previously Håvard has been working with characterisation and manufacturing of porous materials for biomedical purposes at the Central Institute for Medical Engineering in Munich (2001-2004), calcification of heart valves at Helmholtz Institute for Biomedical Engineering in Aachen (1999-2000), Germany and scaffolds production for the Tissue Engineering Center at Imperial College, London (2000-2001). He had a post-doctoral position at Department of Biomaterials from 2005-2009 with funding for the Norwegian Research Council and FUNMAT. Since 2013 he has been Associate Professor and Head of Department of Biomaterials, and Professor in Biomaterials since 2014. He is currently involved in bone graft material/scaffold production funded by the Norwegian Research Council and EU Eureka-Eurostar. Other research interests are porous materials, surface modification and intrinsic disorder proteins.
University of Aarhus, Denmark
Henrik Birkedal obtained his PhD with honors from Université de Lausanne, Switzerland, followed by a postdoc at University of California, Santa Barbara. In 2004, he was awarded a stipend to establish his own research program at Aarhus University where he is now an associate professor and leads a research group with the area of biological and bioinspired materials.
University of Oslo, Norway
Janne Reseland received a Doctor of Science in Biochemistry at the Department of Biochemistry, University of Oslo in 1995, based on work done at the Norwegian Food Research Institute and at the Oslo Biotechnology Centre. She was at the Institute for Nutrition Research, Faculty of Medicine, University of Oslo, for a period of 7 years as postdoc fellow and research scientist. In 2003 Reseland started working on an EU founded project on development of stable extracellular matrices as novel biotherapeutics for biomimetic induction of hard tissue growth at the Institute for Clinical Dentistry, Faculty of Dentistry, University of Oslo. Reseland became an associate professor in 2005, and a professor in Biomaterials in 2007 at the Department of Biomaterials, and is currently (since 2010) head of the Oral Research Laboratory. Reseland has been working on different aspects of adipokines, expression and effects, since 1996, and was instrumental in identifying the expression of adipokines (leptin, adiponectin and resistin) in bone. Main focus has been examination of primary human bone cells, bone remodeling and quality since 2001. She has been a board member of the Norwegian Forum for Bone Research since 2011.
University of Iceland, Iceland
Már Másson, completed his BS in chemistry (University of Iceland, 1987), Cand. Scient (MS) organic chemistry (Copenhagen University, Denmark, 1990) and graduated as Doctor of Engineering – Biotechnology (Tokyo Institute of Technology, Japan, 1995). He became Post-Doc at University of Iceland 1995, Assoc. Prof. in medicinal chemistry in 1998 and since 2005 he has been a Professor in Medicinal Chemistry at University of Iceland, Faculty of Pharmaceutical Sciences. Már Másson research was initially field on biosensors and analytical technology but in recent years his research group had focused on chemical modification of natural compounds for drug delivery and antimicrobial action. He has mainly worked on derivatives of chitosan biopolymer and has developed a TBDMS protection strategy that can be utilized for chemoselective and highly controlled synthesis chitosan derivatives. Number of applications has been investigated including chitosan derivatives as antimicrobial agents, permeation enhancers affecting tight-junctions in pulmonary epithelium, coatings for application in regenerative medicine and chitosan nanocarriers for photochemical internalization in cancer treatment. Már Másson has an active collaboration with engineers and mathematicians focused on the developing accurate mathematical models, which require numerical solutions to describe for drug delivery processes and drug delivery systems.
University of Minho. Portugal
Tiago H. Silva is Assistant Researcher at 3B’s Research Group, ICVS/3B’s Associated Laboratory – University of Minho (Portugal), being coordinator of Marine Inspired Biomaterials and Valorization of Marine Resources and Byproducts research line. He his graduated in Chemistry (2001) and PhD in Chemistry (2006), both by Faculty of Sciences – University of Porto (Portugal) working in surface modification by electrostatic layer-by-layer self-assembly of polyelectrolyte multilayers, and was visiting researcher at the Swiss Federal Institute of Technology in Lausanne (EPFL, Switzerland) in 2003.
He has more than 11 years of experience in valorization of marine byproducts and his research focusing on the cross-talk of blue and red biotechnologies, by aiming the development of marine inspired biomaterials for regenerative medicine strategies, namely addressing bone, cartilage and cornea tissue engineering, as well as diabetes and cancer therapies. His team has established methodologies for the production of biopolymers (fish collagen, squid chitosan, fucoidan) from marine resources and derived byproducts and their processing as porous structures, hydrogels, membranes and particles. Marine biomimetics is also being explored, looking into particular features and phenomena of marine sponges as inspiration for the design of innovative biomedical applications and smart materials.